[{"data":1,"prerenderedAt":48},["ShallowReactive",2],{"q-nurse-114-3-basic-medicine-040":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":24},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":23},"nurse-114-3-基礎醫學-040","nurse-114-3-basic-medicine-040",114,3,40,"下列何者為人源性單株抗體（ humanized monoclonal antibody），用於免疫抑制誘導治療（induction immunosuppressant therapy）？",{"A":15,"B":16,"C":17,"D":18},"alemtuzumab","methylprednisolone","rituximab","cyclosporine","A",null,[],"本題考點在於免疫抑制誘導治療所用的單株抗體種類。依單株抗體命名與標的判斷，alemtuzumab為抗CD52的人源化(humanized)單株抗體，能廣泛清除T、B淋巴球，臨床用於器官移植的免疫誘導與難治性排斥，(A)正符合「人源化單株抗體且用於誘導免疫抑制」的條件，故選A。(B)methylprednisolone為皮質類固醇，非抗體；(C)rituximab為抗CD20的嵌合型(chimeric)單株抗體，主用於B細胞淋巴瘤與自體免疫病；(D)cyclosporine為抑制calcineurin的小分子藥，皆不符題意。",1,[25,29,33,36,40,44],{"webId":26,"stem":27,"number":23,"year":28,"session":23},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",106,{"webId":30,"stem":31,"number":32,"year":28,"session":23},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",2,{"webId":34,"stem":35,"number":11,"year":28,"session":23},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",{"webId":37,"stem":38,"number":39,"year":28,"session":23},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":41,"stem":42,"number":43,"year":28,"session":23},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":45,"stem":46,"number":47,"year":28,"session":23},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840773059]